Lung transplant outcomes in bronchiectasis -a single center experience
Conclusion: BE accounts for 11,2% of all LTx done in our center, a distribution that is superior to ISHLT registry. Comparing to all LTx pts we recognize a good BE post-transplant outcome, with a similar survival rate at 1-year and even superior at 5-years. These results reinforce the need to referral pts with severe and end stage BE and supports the role of LTx as valuable treatment for this disease.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Duarte Ferreira Dantas, C., Santos, A. S., Silva, D., Reis, J. E., Calvinho, P., Semedo, L., Cardoso, J. Tags: Transplantation Source Type: research
More News: Cystic Fibrosis | Lung Transplant | Portugal Health | Respiratory Medicine | Transplant Surgery | Transplants